drugset / Trial / NCT03050398
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
NaSingle-groupOpen-labelOther
Summary
This study was a companion study to CLEE011A2404 which provided the opportunity for the collection of tumor tissue samples to better understand relevant mutations and the mechanisms responsible for resistance to treatment.
Timeline
- Start
- 2017-06-07
- Primary completion
- 2019-03-08
- Completion
- 2019-03-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Letrozole | Other / unclassified | — | — |
| Background | Ribociclib | Small molecule | — | — |